AU2001263418A1 - Yeast strains to identify specific inhibitors of polo kinases - Google Patents

Yeast strains to identify specific inhibitors of polo kinases

Info

Publication number
AU2001263418A1
AU2001263418A1 AU2001263418A AU6341801A AU2001263418A1 AU 2001263418 A1 AU2001263418 A1 AU 2001263418A1 AU 2001263418 A AU2001263418 A AU 2001263418A AU 6341801 A AU6341801 A AU 6341801A AU 2001263418 A1 AU2001263418 A1 AU 2001263418A1
Authority
AU
Australia
Prior art keywords
yeast strains
identify specific
specific inhibitors
polo kinases
polo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263418A
Inventor
Raymond Erikson
Kyung S. Lee
Sukgil Song
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
National Institutes of Health NIH
Original Assignee
Harvard College
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, US Department of Health and Human Services filed Critical Harvard College
Publication of AU2001263418A1 publication Critical patent/AU2001263418A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001263418A 2000-05-23 2001-05-23 Yeast strains to identify specific inhibitors of polo kinases Abandoned AU2001263418A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20658800P 2000-05-23 2000-05-23
US60/206,588 2000-05-23
PCT/US2001/016903 WO2001090401A2 (en) 2000-05-23 2001-05-23 Yeast strains to identify specific inhibitors of polo kinases

Publications (1)

Publication Number Publication Date
AU2001263418A1 true AU2001263418A1 (en) 2001-12-03

Family

ID=22767046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001263418A Abandoned AU2001263418A1 (en) 2000-05-23 2001-05-23 Yeast strains to identify specific inhibitors of polo kinases

Country Status (2)

Country Link
AU (1) AU2001263418A1 (en)
WO (1) WO2001090401A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058161A2 (en) * 2002-12-20 2004-07-15 Fmc Corporation Hemipteran polo-like kinases
GB0326396D0 (en) * 2003-11-12 2003-12-17 Cyclacel Ltd Method
US7968762B2 (en) 2004-07-13 2011-06-28 Van Andel Research Institute Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
US9289475B2 (en) 2008-11-06 2016-03-22 The Johns Hopkins University Treatment of chronic inflammatory respiratory disorders
EP2258858A1 (en) 2009-06-05 2010-12-08 Universitätsklinikum Freiburg Transgenic LSD1 animal model for cancer
WO2011071916A2 (en) 2009-12-07 2011-06-16 The Johns Hopkins University Sr-bi as a predictor of human female infertility and responsiveness to treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650501A (en) * 1994-06-02 1997-07-22 Mount Sinai Hospital Corporation Serine/threonine kinase and nucleic acids encoding same

Also Published As

Publication number Publication date
WO2001090401A3 (en) 2002-11-28
WO2001090401A2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2002238418A1 (en) Use of DNA repair enzymes as MMP-1 inhibitors
AU2001228309A1 (en) N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
AU2002213485A1 (en) Inhibitors of protein kinases
AU2002251266A1 (en) Inhibitors of akt activity
AU2002220082A1 (en) Imaging of enzymatic activity
AU2001236720A1 (en) Compositions useful as inhibitors of erk
EP1469873A4 (en) Peptidomimetic inhibitors of post-proline cleaving enzymes
AU2001241078A1 (en) Alpha-amylase activity inhibitors
AU2003261319A1 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
AU2001270200A1 (en) Fatty acid synthase inhibitors
AU2002235168A1 (en) Targeting pluripotent stem cells to tissues
AU2001296821A1 (en) Methods of inhibiting angiogenesis using nadph oxidase inhibitors
AU2001263418A1 (en) Yeast strains to identify specific inhibitors of polo kinases
AU2001262732A1 (en) Inhibitor for enzyme having two divalent metal ions as active centers
AU2001259990A1 (en) Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
AU2001281059A1 (en) Fatty acid synthase inhibitors
AU2002223666A1 (en) Use of enzymes obtained from ciliates as medicaments for promoting digestion
AU2002309330A1 (en) Isolation method of mesenchymal cells
AU7125700A (en) Enzyme inhibitors
AU2002239258A1 (en) Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon
AU2001229530A1 (en) Detection of fermentation-related microorganisms
AU2001271531A1 (en) Fatty acid synthase inhibitors
AU2001232079A1 (en) Water dispersible formulation of paroxetine
AU2001274940A1 (en) Fatty acid synthase inhibitors
AU2002243439A1 (en) Fatty acid synthase inhibitors